TRICARE Pharmacy Program RFI (Draft Section C & H)

Key Dates
Due Date

-

Posted Date

-

Agency & Value
Agency

DEFENSE HEALTH AGENCY

Contract Value

Not provided

Codes & Classification
Solicitation Number

-

NAICS

524114 - Direct Health and Medical Insurance Carriers

Classification Code

Q201

Additional Details
Set Aside

None

Place of Performance

UNITED STATES

SourceSAM
Documents3
The Defense Health Agency (DHA), operating under the Department of Defense, has issued a Special Notice as part of its acquisition planning for the next generation TRICARE Pharmacy Program contract, referred to as TPharm6. This notice serves as a Request for Information (RFI) and is specifically aimed at soliciting industry feedback on two critical draft documents: Section C (Statement of Work) and Section H (Special Contract Requirements). The intent is to refine and enhance the program’s requirements and contractual framework prior to the formal solicitation phase. The TRICARE Pharmacy Program is a cornerstone of the military health system, providing comprehensive pharmacy benefits to eligible beneficiaries across the United States. The scope of this procurement encompasses the administration and management of pharmacy benefits, with the overarching goal of ensuring high-quality, accessible, and cost-effective pharmaceutical services for TRICARE members. The anticipated outcomes include improved service delivery, operational efficiency, and compliance with federal healthcare standards. Key requirements and objectives outlined in the draft documents are expected to address the full lifecycle of pharmacy benefit management, including but not limited to claims processing, network management, beneficiary support, and adherence to regulatory and contractual obligations. The DHA is seeking industry input to ensure that the Statement of Work and Special Contract Requirements are both practical and comprehensive, reflecting current best practices and innovations in pharmacy benefit administration. The procurement is classified under NAICS Code 524114 (Direct Health and Medical Insurance Carriers), with a Product Service Code of Q201, indicating a focus on medical services. The place of performance is within the United States. The contracting activity is managed by the Defense Health Agency, with the primary office located under the Office subtype, and is identified by organization key 100142347. Interested vendors are invited to review the draft documents and provide detailed feedback, questions, or comments. All responses specific to Section C and Section H must be submitted via email to [email protected] by May 11, 2026, at 12:00 PM Mountain Time. The subject line should include the company name and reference to the draft documents response. Additionally, the DHA is offering the opportunity for one-on-one meetings with industry stakeholders to discuss the draft requirements in greater detail. Requests for these meetings must also be submitted by the same deadline using the provided online form. The primary points of contact for this notice are Viktoria Reed ([email protected], 303-676-3648) and Brooke Wolfe ([email protected], 303-676-3799). The notice remains active and can be accessed through the official SAM.gov portal (Opportunity ID: eaa633bbca404ab9bf2e07b9d10a084d). This RFI does not constitute a formal solicitation, nor does it commit the government to any contractual action. Rather, it represents a critical opportunity for qualified contractors with experience in health and pharmacy benefit management to influence the structure and requirements of a major federal healthcare program. Contractors are encouraged to assess the alignment of their capabilities with the anticipated scope and to participate actively in the feedback process to help shape the future of the TRICARE Pharmacy Program.